Jeffrey T. Walsh

2014

In 2014, Jeffrey T. Walsh earned a total compensation of $1.5M as Chief Financial and Strategy Officer at bluebird bio, a 77% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$173,184
Option Awards$1,014,046
Salary$340,400
Total$1,527,630

Walsh received $1M in option awards, accounting for 66% of the total pay in 2014.

Walsh also received $173.2K in non-equity incentive plan and $340.4K in salary.

Rankings

In 2014, Jeffrey T. Walsh's compensation ranked 5,655th out of 13,032 executives tracked by ExecPay. In other words, Walsh earned more than 56.6% of executives.

ClassificationRankingPercentile
All
5,655
out of 13,032
57th
Division
Manufacturing
2,028
out of 4,967
59th
Major group
Chemicals And Allied Products
687
out of 1,690
59th
Industry group
Drugs
533
out of 1,369
61st
Industry
Biological Products, Except Diagnostic Substances
98
out of 241
59th
Source: SEC filing on April 21, 2017.

Walsh's colleagues

We found five more compensation records of executives who worked with Jeffrey T. Walsh at bluebird bio in 2014.

2014

Nick Leschly

bluebird bio

Chief Executive Officer

2014

James DeTore

bluebird bio

Chief Financial Officer

2014

Jason Cole

bluebird bio

General Counsel

2014

David Davidson

bluebird bio

Chief Medical Officer

2014

Mitchell Finer

bluebird bio

Chief Scientific Officer

News

In-depth

You may also like